About Americord
Americord is a Healthcare company based in New York (United States) founded in 2008 by Martin Smithmyer. It offers cord blood banking services for preserving stem cells for future medical use. It operates on a D2C model. The company has 17 employees. Its chief executive, as recorded, is Martin Smithmyer. Americord offers products and services including Cord Blood Banking, Cord Tissue Banking, Amniotic Placental Tissue Banking, and Exosome Banking. Its focus areas include Biotechnology, Regenerative Medicine, Exosome Banking and Stem Cell Banking. Its legal entity is AMERICORD REGISTRY LLC. Its competitors include ViaCord, CORD:USE Cord Blood and CariCord; 3 of its 3 listed competitors have raised funding.
Company details
Americord specializes in collecting and storing umbilical cord blood, tissue, and related materials to preserve stem cells for potential treatments of conditions like leukemia and blood disorders. The company operates through a direct enrollment process via their website, guiding families from collection to long-term storage. Based in the United States, they serve expecting parents and families, emphasizing transparency and scientific innovation in regenerative medicine. Services include various banking packages tailored to individual needs, ensuring secure preservation for future therapeutic options.
- Headquarters New York, United States
- Employees 17
- Founders Martin Smithmyer
- SectorsHealthcare
- Phone•••• ••••
- Website americordblood.com
- Social LinkedIn X Facebook Instagram
- Legal Name Americord Registry Llc
- Employee Count17
Products & Services of Americord
Americord offers a comprehensive portfolio of products and services, including Cord Blood Banking, Cord Tissue Banking, Amniotic Placental Tissue Banking, and Exosome Banking.
Preserves umbilical cord blood stem cells for FDA-approved treatments.
Stores cord tissue for use in clinical trials and therapies.
Preserves placental tissue for potential regenerative medicine applications.
Collects exosomes for healing and regenerative treatments.
People of Americord
6 people are tracked at Americord (4 in leadership, 2 in team); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
Martin Smithmyer | Founder, CEO | Leadership |
Jared L. Anderson | Director Of Marketing | Leadership |
Casey Stoneman Roberson | Director Of Marketing & Sales | Leadership |
Christina Roccos | Strategic Partner | Leadership |
Jason Seibert | Salesforce Manager | Team |
Jonathan Weinreich | Senior Manager - Product Strategy | Team |
Complete people profiles for Americord
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Americord
Americord has 3 listed competitors in our database, 3 of them funded. They include ViaCord, CORD:USE Cord Blood and CariCord.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viacord.com | 1993 | Hebron, United States | $84.5M | Provider of services for cord blood and stem cell banking | ||
| corduse.com | 2004 | Orlando, United States | $27.03M | Provider of umbilical cord blood stem cell storage services | ||
| caricord.com | 2013 | Aurora, United States | $550,000 | Cord blood and tissue are processed for long-term storage. |
Detailed competitors of Americord
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Americord
Websites that share an audience with Americord (americordblood.com).
Websites whose visitors overlap most with Americord. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| viacord.com | 100% | 100.7K | #263,080 | View details | |
| miraclecord.com | 95% | 69.8K | #575,258 | View details | |
| cryo-cell.com | 58% | 39.9K | #719,386 | View details |
Top companies in Cell Therapy
3 companies that operate in the same segment as Americord (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Americord
Complete news archive for Americord
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Americord
Americord was founded in 2008.
Americord is headquartered in New York, United States. It is registered at New York, New York, United States.
Martin Smithmyer is the CEO of Americord, as recorded in our data. They have also founded this company.
Americord has 17 employees.
Americord specializes in collecting and storing umbilical cord blood, tissue, and related materials to preserve stem cells for potential treatments of conditions like leukemia and blood disorders. The company operates through a direct enrollment process via their website, guiding families from collection to long-term storage. Based in the United States, they serve expecting parents and families, emphasizing transparency and scientific innovation in regenerative medicine. Services include various banking packages tailored to individual needs, ensuring secure preservation for future therapeutic options.
Americord's top competitors include ViaCord, CORD:USE Cord Blood and CariCord.
Americord offers Cord Blood Banking, Cord Tissue Banking, Amniotic Placental Tissue Banking, and Exosome Banking.
Americord operates through Americord Registry Llc.